The History of Drug Laws in the United States
The Controlled Substances Act of 1970 was the next major piece of legislation to address drug use. This act classified drugs according to their medical use, the potential for abuse, and the possibility of creating dependence. According to Uhl (2023), The five classes of drugs are:
- Schedule I: Drugs with no currently accepted medical use and a high potential for abuse
- Schedule II: Drugs with a high potential for abuse but also a legitimate medical use
- Schedule III: Drugs with moderate potential for abuse and a legitimate medical use
- Schedule IV: Drugs with low potential for abuse and a legitimate medical use
- Schedule V: Drugs with very low potential for abuse and a legitimate medical use
Since the passage of the Controlled Substances Act, there have been a number of changes to the drug laws in the United States. For example, the Controlled Substances Analogue Enforcement Act of 1986 made it illegal to manufacture or distribute drugs that are similar to controlled substances. And the Prescription Drug Abuse Prevention Act of 2010 increased penalties for drug trafficking and abuse.
The War on Drugs
One of the most controversial aspects of the War on Drugs has been the use of mandatory minimum sentences for drug offenses. These sentences have resulted in the incarceration of large numbers of people, many of whom are nonviolent offenders (Foundations of Addictions Counseling, n.d.).
The War on Drugs has also been criticized for its disproportionate impact on minority communities. African Americans and Latinos are more likely to be arrested and convicted of drug offenses than white Americans (Foundations of Addictions Counseling, n.d.).
The Future of Drug Laws
In addition to the information above, here are some other things to consider when thinking about the future of drug laws in the United States:
- The rise of the opioid crisis
- The increasing availability of synthetic drugs
- The role of technology in drug trafficking
- The need for more effective prevention and treatment programs
Resources
Capuzzi, D., & Stauffer, M. D. (2019). Foundations of Addictions Counseling (4th ed.). Pearson Education (US). https://bookshelf.vitalsource.com/books/9780135169858
Foundations of Addictions Counseling 1292041943, 1269374508, 9781292041940, 9781269374507. (n.d.). Dokumen.pub. Retrieved August 17, 2023, from https://dokumen.pub/foundations-addictions-counseling-
Uhl, G. R. (2023). Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D. Frontiers in Psychiatry, 14, 1031283. https://doi.org/10.3389/fpsyt.2023.1031283